Mannheimer Swartling

Healthcare and Life Sciences

Camilla Appelgren is the chair of Mannheimer Swartling’s Healthcare and Life Sciences group. She has extensive experience advising clients in the pharmaceutical, medical technology, biotech, food and cosmetics industries.

Camilla’s work covers regulatory issues, contract negotiations, research collaborations, clinical trials, market access, licensing, and other commercial matters such as manufacturing, supply, and distribution. She also advises on healthcare compliance, including marketing, cooperation with healthcare professionals, and funding of external research projects.

Camilla regularly represents clients before Swedish authorities and courts in pricing, reimbursement and substitution matters, and also assists with corporate transactions, including acquisitions and investments within the life sciences sector.

Camilla has broad experience in complex data protection issues, particularly in clinical trials, and works with a wide range of clients — from established pharmaceutical and medical device companies to hospitals, research institutions and investors.

Partner, Mannheimer Swartling, 2020- Partner, Calissendorff Swarting, 2015-2020 Associate, Setterwalls, 2006-2015 Secondment, Holland & Knight LLP, New York, 2010 Stockholm District Court, 2004-2006 Secretary, Stockholm Ethical Committee on Animal Research, 2004-2006

Swedish, English

Swedish Bar Association, 2009 International Bar Association

LL.M. (Lund University, 2003) B.Sc. (Lund University, School of Economics and Management, 2004) Studies in international financial and banking law (London School of Economics and Queen Mary, University of London, 2001)